India Proposes Biomanufacturing Working Group With Delaware
ECONOMY & POLICY

India Proposes Biomanufacturing Working Group With Delaware

Union Minister for Science and Technology Dr Jitendra Singh proposed a small India–Delaware biomanufacturing working group to convert discussions into collaborations in research, manufacturing and startup ecosystems. The proposal was made during his meeting with a visiting US delegation led by Delaware Governor Matt Meyer at Seva Teerth. Both sides focused on bilateral collaboration in pharma, biotechnology, clean energy and innovation-led industrial growth.

The minister said science, technology and biotechnology are a key pillar of the India–US strategic partnership and that India seeks deeper engagement with US states that have strong innovation ecosystems. He highlighted India’s emergence as a hub for biotechnology and pharmaceutical innovation, with capacities from research and development to large-scale, cost-efficient manufacturing. He noted the Council of Scientific and Industrial Research, with 37 laboratories and over 7,500 scientists, anchors much of the country’s industrial research effort.

He cited Delaware’s bio-science ecosystem and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as potential collaborators in advanced biomanufacturing, AI-enabled processes and rapid scale-up technologies. He said India’s manufacturing strengths and Delaware’s proximity to major US pharmaceutical companies can support co-development of affordable biologics, biosimilars and vaccines for global health.

He outlined avenues for cooperation including joint biomanufacturing platforms, translational research bridges, startup incubation and workforce co-training in Good Manufacturing Practice manufacturing, regulatory science and quality systems. He identified regulatory science alignment and resilient supply chains for biopharmaceutical inputs as priorities. He noted that the Ministry of Science and Technology supports around 150 incubators and that the government has established a Rs one trillion (tn) research, development and innovation fund to catalyse private-sector and deep-tech investment.

Delegation members from government, universities and industry discussed opportunities in clean hydrogen, workforce development, startup incubation and corporate incorporation frameworks. Both sides agreed that a structured working group would carry discussions into actionable programmes such as joint research calls, startup exchanges and institutional partnerships, adding a state-level dimension to the India–US strategic partnership.

Union Minister for Science and Technology Dr Jitendra Singh proposed a small India–Delaware biomanufacturing working group to convert discussions into collaborations in research, manufacturing and startup ecosystems. The proposal was made during his meeting with a visiting US delegation led by Delaware Governor Matt Meyer at Seva Teerth. Both sides focused on bilateral collaboration in pharma, biotechnology, clean energy and innovation-led industrial growth. The minister said science, technology and biotechnology are a key pillar of the India–US strategic partnership and that India seeks deeper engagement with US states that have strong innovation ecosystems. He highlighted India’s emergence as a hub for biotechnology and pharmaceutical innovation, with capacities from research and development to large-scale, cost-efficient manufacturing. He noted the Council of Scientific and Industrial Research, with 37 laboratories and over 7,500 scientists, anchors much of the country’s industrial research effort. He cited Delaware’s bio-science ecosystem and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as potential collaborators in advanced biomanufacturing, AI-enabled processes and rapid scale-up technologies. He said India’s manufacturing strengths and Delaware’s proximity to major US pharmaceutical companies can support co-development of affordable biologics, biosimilars and vaccines for global health. He outlined avenues for cooperation including joint biomanufacturing platforms, translational research bridges, startup incubation and workforce co-training in Good Manufacturing Practice manufacturing, regulatory science and quality systems. He identified regulatory science alignment and resilient supply chains for biopharmaceutical inputs as priorities. He noted that the Ministry of Science and Technology supports around 150 incubators and that the government has established a Rs one trillion (tn) research, development and innovation fund to catalyse private-sector and deep-tech investment. Delegation members from government, universities and industry discussed opportunities in clean hydrogen, workforce development, startup incubation and corporate incorporation frameworks. Both sides agreed that a structured working group would carry discussions into actionable programmes such as joint research calls, startup exchanges and institutional partnerships, adding a state-level dimension to the India–US strategic partnership.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code